BNET Industries
Market Cap:$3.2B
Last Fiscal Year Sales:$56.7M
- Public
- CA
Dow Jones Description
Adaltis Inc. is an international in-vitro diagnostic company having its headquarters in Montreal, Canada. Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases, and measure human hormone responses.
President, Chief Executive Officer
Pierre LarochelleNumber of Employees 261
Peer Companies
NAICS Code Surgical Appliance and Supplies Manufacturing: 339113
News & Analysis
Filter by
adaltis inc. - All News and Analysis
Alliance Data Systems Corporation Q3 2009 Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions Your first question comes from the line of James Kissane - Banc of America/ Merrill Lynch. James Kissane - Banc of America/ Merrill Lynch. Hey does your 2010 guidance include Charming? I just want to confirm that and maybe review what Charming can...
Adaltis Inc. Announces Bankruptcy Act Filing
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that it has filed a voluntary assignment in bankruptcy under the Bankruptcy and Insolvency Act Canada in order to effect an orderly liquidation of its assets, property and operations. The filing of said assignment...
Adaltis Announces Resignations From its Board of Directors
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that the following directors had resigned from its Board of Directors: Messrs. Peter Kruyt, Pierre Larochelle and Victor Yang. As a result of these resignations, the current Board of Directors of Adaltis is composed of:...
Adaltis Inc. Obtains an Order Establishing a Claims Process
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that it has obtained an order from the Quebec Superior Court establishing a claims process for the purpose of determining the claims of the creditors of Adaltis and for the calling and conducting of a...
Adaltis Inc. Shares to Be Delisted as Part of its Reorganization
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that it has been advised by the Toronto Stock Exchange ("TSX") that its common shares will be delisted at the close of market on August 6, 2009 for failure to meet the continued listing requirements...
Adaltis Inc. Obtains Court Order for Creditor Protection
Further to a news release issued this morning and the completion of subsequent proceedings before the Quebec Superior Court, Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that it has obtained an Order for creditor protection under the Companies' Creditors Arrangement Act Canada....
IIROC: Halt; Adaltis Inc.
TORONTO, ONTARIO, Jun 29, 2009 Marketwire via COMTEX -- Company / Compagnie Adaltis Inc. TSX Symbol / Symbole ...
Adaltis Inc. Obtains Additional Bridge Loan
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that it has secured an additional bridge loan of up to $2 million from Victoria Square Ventures Inc. and has issued this day a promissory note in the aggregate principal amount of $750,000 to Victoria...
Adaltis Inc. Obtains Additional Bridge Loan.
MONTREAL, QUEBEC, Jun 22, 2009 Marketwire via COMTEX -- Adaltis Inc. (TSX:ADS), an international in vitro diagnostic IVD company, today announced that it has secured an additional bridge loan of up to $2 million from Victoria Square Ventures Inc. and has issued this day a...
Adaltis Inc. Obtains $3 Million Bridge Loan
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced that it has issued promissory notes in the aggregate principal amount of $3 million to Clarity China Partners, L.P. and one of its affiliates and Victoria Square Ventures Inc. The notes are secured by certain...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Pierre Larochelle | President, Chief Executive Officer |
| Eddy Miller | Vice President, Finance and Chief Financial Officer, Director, Investor Relations |
| Frederick Leung | Chief Operating Officer, China |
| Jacques Deforges | Vice President, Finance, Chief Financial Officer |
| Raymond Tong | Chief Operating Officer |
| Dennis Fu | Executive Vice President, Global Operations |
| Sandro Scagnoli | Executive Vice President, Head of International Business |
| Giuseppe Biondi | Vice President, Business Development |
| Jacopo Malacarne | Vice President, Strategic Development |
| Jacques Milette | Vice President, Sales & Marketing |
| Keith Flavell | Vice President, Legal Affairs, Corporate Secretary |
| Michel Houde | Head, Development |
| Steve Kwok Man | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Francois M. Legault | Board of Directors |
| Joseph Rus | Board of Directors |
| Kwok Man Leung | Board of Directors |
| Lang Michener | Board of Directors |
| Matteo Tamburini | Board of Directors |
| Orlando Antonini | Board of Directors |
| Peter Kruyt | Board of Directors |
| Richard J. Renaud | Board of Directors |
| Sergio Marchi | Board of Directors |
Mr. Larochelle was formerly Vice president, Business development at Picchio Pharma Inc., a Montreal-based holding company investing in the biotechnology sector. Prior to joining Picchio Pharma, Mr. Larochelle was Vice President, Mergers and Acquisitions for Credit Suisse First Boston in London.
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | President, Chief Executive Officer | Current |
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Vice President, Finance and Chief Financial Officer, Director, Investor Relations | Current |
| Christensen & Associates | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Chief Operating Officer, China | Current |
| Siemens AG | Regional Strategic Development Director, Asia-Pacific, Siemens Healthcare Diagnostic | Former |
| Beckman Coulter, Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Vice President, Finance, Chief Financial Officer | Current |
| Boomerang Tracking Corporation | President and Chief Financial Officer | Former |
| Celmed BioSciences, Inc. | President and Chief Financial Officer | Former |
| National Bank of Canada | Vice President | Former |
| Celmed BioSciences, Inc. | Vice President | Former |
| Boomerang Tracking Corporation | Vice President | Former |
| National Bank of Canada | Senior Manager | Former |
| Concordia University | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Chief Operating Officer | Current |
| Adaltis Inc. | Chairman, Shanghai Cp Adaltis Diagnostics Co. Ltd. | Current |
| Citic Pacific Limited | Former | |
| University of Toronto | Former |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Executive Vice President, Global Operations | Current |
| University Corp. | Degree In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Executive Vice President, Head of International Business | Current |
| Adaltis Inc. | Vice President, Operations | Former |
| Adaltis Inc. | Representative | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Vice President, Strategic Development | Current |
| McKinsey & Company, Inc. | Former | |
| INSEAD | Mba | Former |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Vice President, Sales & Marketing | Current |
| Abbott Laboratories | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Vice President, Legal Affairs, Corporate Secretary | Current |
| Bell Canada International, Inc. | Director of Legal Affairs | Former |
| Bell Canada International, Inc. | Board of Directors | Former |
| Yale University | BA | Former |
| University of Ottawa | Degrees | Former |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Head, Development | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Adaltis Inc. | Board of Directors | Current |
Mr. Kwok is a non-executive director of CITIC 1616 and DCH Holdings, a director of Adaltis Inc. (a Canadian listed company), CITIC Guoan, NHKTC and other Group companies concerned with special steel and environment project. He joined CITIC Pacific in 1993 after experience in sales and business development with a major Hong Kong listed Company. Mr. Kwok is 39.
| Organization | Position | Status |
|---|---|---|
| Dch Holdings | Board of Directors | Current |
| Adaltis Inc. | Director | Current |
| Citic Pacific Limited | Board of Directors | Current |
| Volume | 744,353 |
| Shares Outstanding | 52.2M |
| Market Cap | 3.2B |
| Year High | 69.090 |
| Year Low | 22.76 |
| Earnings Per Share | 2.58 |
| P/E Ratio | 24.2442 |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes




